Which patients will benefit most from FXI inhibition?
Session:
How could factor eleven (FXI) inhibitors help your patients? New frontiers in thrombosis prevention
Topic:
Atrial Fibrillation (AF)
Sponsored by Bayer AG
Event:
ESC Congress 2022
Congress Presentation
About the speaker
Professor Vijay Kunadian
Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)
19
presentations
5
followers
3 more presentations in this session
What makes FXI inhibition different from current approaches to thrombosis prevention?
Speaker: Professor V. Caso (Perugia, IT)
Access the full session
How could factor eleven (FXI) inhibitors help your patients? New frontiers in thrombosis prevention
Speakers:
Professor V. Kunadian, Doctor M. Patel, Professor V. Caso
About the event
ESC 365 is supported by
